Clough Capital Partners L P Regeneron Pharmaceuticals, Inc. Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

A detailed history of Clough Capital Partners L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clough Capital Partners L P holds 715 shares of REGN stock, worth $501,822. This represents 0.08% of its overall portfolio holdings.

Number of Shares

715

Previous 715 -0.0%

Holding current value

$501,822

Previous $751,000 -0.0%

% of portfolio

0.08%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $108,525 - $123,438	140 Added 24.35%	715 $627,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $5.01 Million - $6.1 Million	-7,230 Reduced 92.63%	575 $473,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $5.46 Million - $6.48 Million	7,805 New	7,805 $5.61 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $15.5 Million - $18.2 Million	-26,040 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $3.77 Million - $4.66 Million	-6,945 Reduced 21.06%	26,040 $16.4 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $12.9 Million - $15.3 Million	-22,535 Reduced 40.59%	32,985 $20 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $26.2 Million - $31 Million	55,520 New	55,520 $31 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $3.75 Million - $4.6 Million	-8,384 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $7.13 Million - $9.06 Million	-14,908 Reduced 64.0%	8,384 $4.05 Million
Q3 2020 Nov 17, 2020	SELL	$544.75 - $658.21 $3.17 Million - $3.83 Million	-5,823 Reduced 20.0%	23,292 $13 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $4.01 Million - $5.23 Million	-8,120 Reduced 21.81%	29,115 $18.2 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $3.45 Million - $5.07 Million	10,255 Added 38.01%	37,235 $18.2 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $7.4 Million - $10.2 Million	26,980 New	26,980 $10.1 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account

Clough Capital Partners L P Regeneron Pharmaceuticals, Inc. Transaction History